axSpA、pSpA和PsA中健康相关生活质量与整体功能健康状况的决定因素:ASAS-PerSpA研究结果
基于ASAS-PerSpA研究数据,分别分析2719例axSpA、433例pSpA和1033例PsA患者,以EQ-5D评估健康相关生活质量(HRQoL)、ASAS-HI评估整体功能健康状况(GH)。疾病活动和身体功能是各型SpA中HRQoL和GH的主要决定因素,临床特征和社会人口学因素也起重要作用。
要点
- 疾病活动和身体功能是axSpA、pSpA和PsA中HRQoL与GH的主要决定因素。
- 女性性别、纤维肌痛和轴向疾病/受累与更差的HRQoL和GH相关。
- 大学教育和高龄与更好的HRQoL和GH相关。
核心结论
- 疾病活动和身体功能是各型SpA中HRQoL和GH的主要决定因素,临床特征和社会人口学因素起重要作用,强调对个体患者采取整体性方法的重要性。
研究设计与样本
- 分析ASAS-PerSpA研究数据,分别对axSpA、pSpA和PsA三组患者建立模型,探索与EQ-5D评估的HRQoL和ASAS-HI评估的GH相关的因素。
- 分析共纳入4185例患者:axSpA 2719例、pSpA 433例、PsA 1033例。
主要发现
- axSpA中,疾病活动(β=-0.061)、身体功能(β=-0.041)、女性性别(β=-0.019)和纤维肌痛(β=-0.068)与更差HRQoL相关,年龄(β=0.001)和大学教育(β=0.014)与更好HRQoL相关。
- pSpA中,疾病活动(β=-0.04)和身体功能(β=-0.054)与更差HRQoL相关。
- PsA中,疾病活动(β=-0.045)、身体功能(β=-0.053)、轴向疾病(β=-0.041)和女性性别(β=-0.028)与更差HRQoL相关。
- axSpA中,疾病活动(β=0.889)、身体功能(β=0.887)、外周疾病(β=0.564)、女性性别(β=0.812)和纤维肌痛(β=1.639)与更差GH相关,年龄(β=-0.013)和大学教育(β=-0.274)与更好GH相关。
- pSpA中,身体功能(β=1.142)和女性性别(β=1.060)与更差GH相关,大学教育(β=-0.611)与更好GH相关;PsA中,疾病活动(β=0.703)、身体功能(β=1.025)、轴向受累(β=0.659)、女性性别(β=0.924)和纤维肌痛(β=1.387)与更差GH相关,年龄(β=-0.024)和大学教育(β=-0.856)与更好GH相关。
临床怎么用
- 作者认为,疾病活动和身体功能是各型SpA中HRQoL和GH的主要决定因素,临床特征和社会人口学因素也起重要作用,强调对个体患者采取整体性方法的重要性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: We aimed to identify determinants of health-related quality of life (HRQoL) and global functioning and health (GH) in axial SpA (axSpA), peripheral SpA (pSpA) and (PsA). METHODS: The ASAS-perSpA study data were analysed. Models for the three patient groups were run separately to explore factors associated with HRQoL and GH, assessed by EQ-5D and ASAS-HI, respectively. RESULTS: The analyses included 4185 patients: 2719 with axSpA, 433 with pSpA, and 1033 with PsA.In axSpA, disease activity (β = -0.061), physical function (β = -0.041), female sex (β = -0.019) and fibromyalgia (FM) (β = -0.068) were associated with worse HRQoL; age (β = 0.001) and university education (β = 0.014) were associated with better HRQoL. In pSpA, disease activity (β = -0.04) and physical function (β = -0.054) were associated with worse HRQoL. In PsA, disease activity (β = -0.045), physical function (β = -0.053), axial disease (β = -0.041) and female sex (β = -0.028) were associated with worse HRQoL. In axSpA, disease activity (β = 0.889), physical function (β = 0.887), peripheral disease (β = 0.564), female sex (β = 0.812) and FM (β = 1.639) were associated with worse GH; age (β = -0.013) and university education (β = -0.274) were associated with better GH. In pSpA, physical function (β = 1.142) and female sex (β = 1.060) were associated with worse GH; university education (β = -0.611) was associated with better GH. In PsA, disease activity (β = 0.703), physical function (β = 1.025), axial involvement (β = 0.659), female sex (β = 0.924) and FM (β = 1.387) were associated with worse GH; age (β = -0.024) and university education (β = -0.856) were associated with better GH. CONCLUSION: Disease activity and physical function are major HRQoL and GH determinants across SpA types, and clinical characteristics and sociodemographic factors play an important role, highlighting the importance of a holistic approach for individual patients.
引用
- Santos H, Henriques AR, Machado PM, et al. Determinants of health-related quality of life and global functioning and health in axSpA, pSpA and PsA: results from the ASAS-PerSpA study. Rheumatology (Oxford). 2024. PMID: 37738594. doi:10.1093/rheumatology/kead503
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。